Avanos Medical Inc. (AVNS)

AI Score

Unlock

13.42

-0.61 (-4.35%)

At close: Apr 04, 2025, 3:59 PM

13.16

-1.94%

After-hours: Apr 04, 2025, 05:16 PM EDT

Avanos Medical Income Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011
Revenue	687.8M	673.3M	820M	744.6M	714.8M	697.6M	652.3M	611.6M	1.59B	1.57B	1.67B	1.68B	1.68B	1.66B
Cost of Revenue	306.5M	293.6M	370M	380.3M	341.5M	295.4M	261.4M	274.7M	1.03B	1.04B	1.12B	1.07B	1.08B	1.07B
Gross Profit	381.3M	379.7M	450M	364.3M	373.3M	402.2M	390.9M	336.9M	557.9M	531.6M	548.6M	612.2M	602.5M	590.8M
Operating Income	-396.2M	4.2M	74M	8.9M	-46.1M	-55.7M	500K	-43.1M	87.4M	-377.7M	94.3M	225.3M	228M	210.7M
Interest Income	5.1M	2.9M	1.2M	200K	1.2M	6.7M	7.8M	2.5M	600K	300K	2.9M	2.6M	2.6M	4.1M
Pretax Income	-403.3M	-7.9M	65.2M	5.8M	-60.5M	-64M	-18.1M	-72.2M	55.3M	-410.5M	91.2M	227.8M	229.8M	214.6M
Net Income	-392.1M	-61.8M	50.5M	6.3M	-27.2M	-45.9M	57.5M	79.3M	39.8M	-426.3M	27.1M	154.6M	152.6M	142.4M
Selling & General & Admin	318.5M	318.1M	341.9M	300.3M	332.6M	399.1M	340.4M	321.7M	411.1M	398.5M	424.5M	351.4M	343M	351.7M
Research & Development	26.2M	27.2M	30.6M	32.3M	34.9M	37.7M	41.8M	38.2M	41.1M	32.3M	33.6M	37.9M	33M	31.2M
Other Expenses	432.8M	30.2M	3.5M	22.8M	51.9M	21.1M	8.2M	20.1M	18.3M	4.5M	-3.8M	-2.4M	-1.5M	-2.8M
Operating Expenses	777.5M	375.5M	376M	355.4M	419.4M	457.9M	390.4M	380M	470.5M	435.3M	454.3M	386.9M	374.5M	380.1M
Interest Expense	12.2M	15M	10M	3.3M	15.6M	15M	26.4M	31.6M	32.7M	33.1M	6M	100K	800K	200K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	1.08B	669.1M	746M	735.7M	760.9M	753.3M	651.8M	654.7M	1.5B	1.48B	1.58B	1.45B	1.46B	1.45B
Income Tax Expense	-17M	2M	14.7M	600K	-33.3M	-18.1M	-9.6M	-40.1M	15.5M	15.8M	64.1M	73.2M	77.2M	72.2M
Shares Outstanding (Basic)	46M	46.6M	46.9M	48.1M	47.8M	47.6M	47.2M	46.52M	46.6M	46.59M	46.54M	46.51M	46.51M	46.51M
Shares Outstanding (Diluted)	46M	46.6M	47.3M	48.6M	47.8M	47.6M	47.2M	46.8M	47M	46.59M	46.54M	46.51M	46.51M	46.51M
EPS (Basic)	-8.52	-1.33	1.08	0.13	-0.57	-0.96	1.22	1.69	0.85	-9.15	0.58	3.32	3.28	3.06
EPS (Diluted)	-8.52	-1.33	1.07	0.13	-0.57	-0.96	1.22	1.69	0.85	-9.15	0.58	3.32	3.28	3.06
EBITDA	-345.6M	50.6M	77.8M	8.9M	-2M	-12.1M	65.7M	-600K	-65.5M	-76.5M	179.7M	297.1M	288.2M	265.9M
EBIT	-391.1M	7.1M	36.7M	-38.8M	-44.9M	-49M	8.3M	-40.6M	-106.5M	-135.4M	97.2M	225.3M	230.6M	214.8M
Depreciation & Amortization	45.5M	46.1M	41.1M	38.3M	42.9M	36.9M	33.5M	40M	41M	65.4M	85.4M	69.2M	57.6M	51.1M